Telix Pharmaceuticals | TLX - Operating Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Telix Pharmaceuticals

Telix Pharmaceuticals Ltd reported AUD160.59M in Operating Expenses for its fiscal semester ending in December of 2022.


Operating Expenses Change
Cochlear COH:AU AUD 699.5M 37.5M
CSL CSL:AU USD 5.05B 1.24B
Integral Diagnostics Ltd IDX:AU AUD 188.69M 22.23M
Mayne Pharma MYX:AU AUD 270.38M 112.19M
Pacific Edge PEB:NZ NZD 28.27M 4.87M
Paradigm Biopharmaceuticals Ltd PAR:AU AUD 32.96M 12.67M
Polynovo Ltd PNV:AU AUD 32.95M 6.93M
PYC Therapeutics Ltd PYC:AU AUD 20.42M 2.66M
Ramsay Health Care RHC:AU AUD 6.62B 291.7M
ResMed RMD:AU USD 753.55M 78.99M
Sonic Healthcare SHL:AU AUD 3.5B 132.13M